Board of Directors
David Steinberg is currently a Venture Partner at Longwood Fund. He was formerly the Chief Innovation Officer at PureTech Health. As a member of PureTech Health, Mr. Steinberg led the development of a number of programs, including Vedanta Biosciences, Calix and Vor Biopharma. He also co-founded resTORbio during his tenure at PureTech Health.
Previously, Mr. Steinberg was a strategy consultant with the Boston Consulting Group and Vertex Partners, focusing on R&D and product strategy and strategic alliances for Fortune 500 pharmaceutical and biotechnology clients. Mr. Steinberg also worked as a research associate in Procter and Gamble Pharmaceuticals' R&D organization.
He received his BA in Biology with distinction from Cornell University and graduated with high honors from the University of Chicago Booth School of Business with an MBA in Strategy and Finance.